Association between pre-existing Pulmonary Hypertension and COVID-19 related outcomes in inpatient and ambulatory care settings
Pre-existing PH is independently associated with higher in-hospital COVID-19 mortality. In outpatients, COVID-19 positivity was associated with increased mortality over 1 year irrespective of PH status, with highest risk within the first 90 days.
Authors
- Gaurav Choudhary (ORCID: https://orcid.org/0000-0001-9343-5481)
- Wen‐Chih Wu (ORCID: https://orcid.org/0000-0002-2834-2024)
- Stephen W. Waldo (ORCID: https://orcid.org/0000-0003-0678-4873)
- S. Vijayakumar (ORCID: https://orcid.org/0000-0001-5085-1397)
- Madhura Gokhale
- Mary E. Plomondon (ORCID: https://orcid.org/0000-0002-8616-4916)
- Herbert D. Aronow (ORCID: https://orcid.org/0000-0002-9061-7893)
- J. Dawn Abbott (ORCID: https://orcid.org/0000-0002-2560-0155)
- Phinnara Has (ORCID: https://orcid.org/0000-0003-4052-221X)
- Wasiq Sheikh (ORCID: https://orcid.org/0000-0002-8560-2531)
- Matthew Jankowich (ORCID: https://orcid.org/0000-0002-5955-0571)
- Sebhat Erqou (ORCID: https://orcid.org/0000-0001-6763-3804)
- David W. Louis (ORCID: https://orcid.org/0000-0001-8255-1516)
- Sabbagh Marwan
- Emily Corneau
Institutions
- Brigham and Women's Hospital (US)
- Ford Motor Company (United States) (US)
- Henry Ford Health System (US)
- Providence College (US)
- Brown University (US)
- Veterans Health Administration (US)
- Henry Ford Hospital (US)
- Michigan United (US)
- Preusser Research Group (US)
- Lifespan (US)
- Rocky Mountain MS Center (US)
- Michigan State University (US)
- National Patient Safety Foundation (US)
- University of Colorado Denver (US)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-04-24
- DOI
- https://doi.org/10.1371/journal.pone.0321964
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00